Abstract:Intravenous anesthesia with propofol was reported to improve cancer surgical outcomes when compared with inhalational anesthesia. However, the underlying molecular mechanisms largely remain unknown.The anti-tumor effects of propofol and the possible underlying mechanism including altered metabolic and signaling pathways were studied in the current study.The cell viability, proliferation, migration, and invasion of cancer cells were analyzed with CCK-8, Ki-67 staining, wound healing, and Transwell assay, respectively. The protein changes were analyzed with Western blot and immunofluorescent staining. The metabolomics alteration was studied with 1H-NMR spectroscopy. The gene expression regulations were analyzed with PCR gene array and qRT-PCR experiments.In this study, we found that propofol reduced cell viability and inhibited cell proliferation, migration and invasion of lung cancer cells, but not neuroglioma cells. In lung cancer cells, propofol downregulated glucose transporter 1 (GLUT1), mitochondrial pyruvate carrier 1 (MPC1), p-Akt, p-Erk1/2, and hypoxia- inducible factor 1 alpha (HIF-1 α ) expressions and upregulated pigment epithelium-derived factor (PEDF) expression. Propofol increased intracellular glutamate and glycine but decreased acetate and formate whilst increased glucose, lactate, glutamine, succinate, pyruvate, arginine, valine, isoleucine, and leucine and glycerol, and decreased acetate, ethanol, isopropanol in the culture media of lung cancer cells. Furthermore, VEGFA, CTBP1, CST7, CTSK, CXCL12, and CXCR4 gene expressions were downregulated, while NR4A3, RB1, NME1, MTSS1, NME4, SYK, APC, and FAT1 were upregulated following the propofol treatment. Consistent with the phenotypical changes, these molecular and metabolic changes were not found in the neuroglioma cells.Our findings indicated anti-tumor effects of propofol on the lung cancer but not brain cancer, through the regulation of tumor metastasis-related genes, multi-cellular signaling and cellular metabolism.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302575-ga1_lrg.jpg">Download : Download high-res image (102KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302575-ga1.jpg">Download : Download full-size image</a></li></ol>

Anesthetic Drug Propofol Inhibits the Expression of Interleukin-6, Interleukin-8 and Cyclooxygenase-2, a Potential Mechanism for Propofol in Suppressing Tumor Development and Metastasis.

Propofol Exerts Anti-Hepatocellular Carcinoma by Microvesicle-Mediated Transfer of Mir-142-3p from Macrophage to Cancer Cells

Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating Mir-374A in Hepatocarcinoma Cell Lines

Propofol Inhibits the Adhesion of Hepatocellular Carcinoma Cells by Upregulating Microrna-199A and Downregulating MMP-9 Expression.

Effects of Propofol on Colon Cancer Metastasis Through STAT3/HOTAIR Axis by Activating WIF‐1 and Suppressing Wnt Pathway

Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression.

Suppressive effect of the anesthetic propofol on the T cell function and T cell-dependent immune responses

Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3

Suppression of Cell Invasion and Migration by Propofol Are Involved in Down-Regulating Matrix Metalloproteinase-2 and P38 Mapk Signaling in A549 Human Lung Adenocarcinoma Epithelial Cells

Propofol Stimulates Immune Activity and Decreases Inflammatory Cytokines via NF-κB-Mediated JAK1-STAT3 Pathway in Gastric Cancer Patients Undergoing Radical Surgery

Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer

The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway

Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk

Anesthetic Propofol Promotes Tumor Metastasis in Lungs via GABA A R‐Dependent TRIM21 Modulation of Src Expression

Propofol suppresses the growth and invasion of cervical carcinoma cells by inhibiting MIR155HG

The Benefits of Propofol on Cancer Treatment: Decipher Its Modulation Code to Immunocytes

Anesthetic propofol inhibits ferroptosis and aggravates distant cancer metastasis via Nrf2 upregulation

Gaba-Receptor Agonist, Propofol Inhibits Invasion Of Colon Carcinoma Cells

Propofol overcome Tamoxifen resistance in breast cancer by modulating tumorogenesis, immune response and metabolism

Propofol suppresses non-small cell lung cancer progression by modulating circ_0001727/miR-516b-5p/LRRC1 axis

Effects of propofol on the development of cancer in humans